Iceland· IS-EU/1/25/1996/001

Waskyra

A medicinal product containing autologous cd34+ haematopoietic stem cells transduced ex vivo with a lentiviral vector encoding human wiskott-aldrich syndrome protein, registered in Iceland by Fondazione Telethon ETS.

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedWaskyraATC—REGISTER NO.IS-EU/1/25/1996/001PACKS LISTED0CHECKEDSeptember 29, 2026

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Autologous CD34+ haematopoietic stem cells transduced ex vivo with a lentiviral vector encoding human Wiskott-Aldrich syndrome protein
Manufacturer
Fondazione Telethon ETS
Country
Iceland (IS)
ATC code
—
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/de8503e3-f280-4a11-9285-80b95b7d129e
GET /v1/drugs/de8503e3-f280-4a11-9285-80b95b7d129e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Innrennslislyf, ördreifa",
  "source": "lyfjastofnun",
  "atc_raw": ".",
  "marketed": false,
  "strength": "2-10 x 10^6 frumur/ml",
  "ma_number": "EU/1/25/1996/001",
  "substance": "Autologous CD34+ haematopoietic stem cells transduced ex vivo with a lentiviral vector encoding human Wiskott-Aldrich syndrome protein",
  "other_info": "Markaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
  "legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
  "ma_issued_serial": "46031"
}

See everything about autologous cd34+ haematopoietic stem cells transduced ex vivo with a lentiviral vector encoding human wiskott-aldrich syndrome protein.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.